Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vitamin D Levels and Vitamin D Education in Geriatric Patients

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT00273611
First received: January 4, 2006
Last updated: November 18, 2013
Last verified: November 2013

January 4, 2006
November 18, 2013
December 2005
May 2006   (final data collection date for primary outcome measure)
25(OH) vitamin D level [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Change in vitamin D level after usual care or pharmacist education
25(OH) vitamin D level
Complete list of historical versions of study NCT00273611 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Vitamin D Levels and Vitamin D Education in Geriatric Patients
Characterization of Vitamin D Levels and Affect of Pharmacist-initiated Vitamin D Education in Geriatric Outpatients.

Vitamin D is important to maintain good health. Although it is found in foods and vitamins, many people still have low vitamin D levels. One purpose of this study is to describe vitamin D levels from patients at the University of Colorado Seniors Clinic. Another goal of the study is to find out if education by a pharmacist can increase vitamin D levels in patients who have low vitamin D levels.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
  • Vitamin D Insufficiency
  • Vitamin D Deficiency
Behavioral: Pharmacist Education about Vitamin D
  • Experimental: Pharmacist education
    Pharmacist education about vitamin D
    Intervention: Behavioral: Pharmacist Education about Vitamin D
  • No Intervention: Usual care
    Usual care
Vande Griend JP, Linnebur SA, Ruscin JM, Vondracek SF, Wolfe P, McDermott MT. Vitamin D intervention by pharmacists in geriatric outpatients. J Am Pharm Assoc (2003). 2008 Jul-Aug;48(4):501-7. doi: 10.1331/JAPhA.2008.07056.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
80
May 2006
May 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient at the University of Colorado Hospital Seniors Clinic with an appointment in December 2005 or January 2006
  • Age 65-89 years

Exclusion Criteria:

  • History of dementia or memory loss
  • Severe illness or life expectancy less than 6 months
  • Assistance with medications from an assisted living facility
  • History of celiac Sprue, Crohn's disease, or chronic pancreatitis
  • High calcium levels, high parathyroid hormone levels, low phosphorus levels, or very high vitamin D levels
  • Taking prescription vitamin D
Both
65 Years to 89 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00273611
05-0799, 5M01RR000051
No
University of Colorado, Denver
University of Colorado, Denver
National Center for Research Resources (NCRR)
Principal Investigator: Sunny Linnebur, Pharm.D. University of Colorado, Denver
University of Colorado, Denver
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP